Servier Pharma Files SC TO-C on Day One Bio: Acquisition Talk Brewing?
| Field | Detail |
|---|---|
| Company | Sc To-C - Day One Biopharmaceuticals, Inc. (0001845337) (Subject) |
| Filed Date | Mar 23, 2026 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | mixed |
Complexity: simple
Sentiment: mixed
Topics: tender-offer, acquisition-talk, corporate-action
TL;DR
**Servier Pharma just filed an SC TO-C on Day One Bio, signaling potential acquisition talks are heating up.**
AI Summary
This SC TO-C filing, submitted on March 23, 2026, by Servier Pharmaceuticals LLC, relates to Day One Biopharmaceuticals, Inc. and indicates a written communication concerning a potential tender offer or other significant transaction. While the specific details of the communication aren't fully disclosed in this summary, the filing itself signals that Servier Pharmaceuticals is actively engaging with Day One Biopharmaceuticals, which could lead to a change in ownership or control. This matters to stockholders because such communications often precede acquisition offers, which can significantly impact the stock price and future prospects of Day One Biopharmaceuticals.
Why It Matters
This filing suggests Servier Pharmaceuticals is communicating about a potential transaction with Day One Biopharmaceuticals, which could lead to an acquisition and a significant change for Day One's shareholders.
Risk Assessment
Risk Level: medium — The filing indicates a potential transaction, which introduces both upside (acquisition premium) and downside (deal falling through, unfavorable terms) risks for investors.
Analyst Insight
A smart investor would monitor Day One Biopharmaceuticals (0001845337) closely for further announcements regarding a potential tender offer or acquisition from Servier Pharmaceuticals (0001842321), as this filing often precedes more definitive transaction details.
Key Players & Entities
- Servier Pharmaceuticals LLC (company) — the entity filing the SC TO-C
- Day One Biopharmaceuticals, Inc. (company) — the subject company of the SC TO-C filing
- March 23, 2026 (date) — the filing date of the SC TO-C
FAQ
What is the purpose of Servier Pharmaceuticals LLC filing an SC TO-C regarding Day One Biopharmaceuticals, Inc.?
The SC TO-C form, as indicated by the filing, is a 'Written communication relating to an issuer or third party.' This suggests Servier Pharmaceuticals LLC is communicating about a potential tender offer or other significant transaction involving Day One Biopharmaceuticals, Inc.
When was this SC TO-C filing submitted and accepted by the SEC?
The filing was submitted and accepted on March 23, 2026, with an acceptance time of 17:16:37.
Filing Stats: 1,717 words · 7 min read · ~6 pages · Grade level 17.5 · Accepted 2026-03-23 17:16:37
Key Financial Figures
- $0.0001 — ns (Parent of Offeror)) Common stock, $0.0001 par value per share (Title of Class o
Filing Documents
- d31459dsctoc.htm (SC TO-C) — 24KB
- d31459dex991.htm (EX-99.1) — 4KB
- g31459ex99_1s1g1.jpg (GRAPHIC) — 106KB
- g31459ex99_1s2g1.jpg (GRAPHIC) — 101KB
- g31459ex99_1s3g1.jpg (GRAPHIC) — 97KB
- g31459ex99_1s4g1.jpg (GRAPHIC) — 86KB
- 0001193125-26-119687.txt ( ) — 567KB
Forward-Looking Statements
Forward-Looking Statements This communication contains forward-looking statements that provide Servier's and the Company's expectations or forecasts of future events such as new product introductions, product approvals and financial performance and forward-looking statements regarding Servier's proposed acquisition of the Company, including regarding prospective benefits of the proposed acquisition, regarding the anticipated occurrence, manner and timing of the proposed tender offer and the closing of the proposed acquisition, regarding the Company's product candidates and ongoing clinical and preclinical development, and regarding the accounting treatment of the potential acquisition under GAAP and its potential impact on Servier's financial results and financial guidance. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like "believe", "anticipate", "expect", "estimate", "intend", "plan", "project", "will be", "will continue", "will result", "could", "may", "might", or any variations of such words or other words with similar meanings. All statements other than statements of historical facts included in this communication, including, without limitation, those regarding the Servier Parties' and the Company's financial positions, business strategies, plans and objectives of management for future operations (including development plans and objectives relating to the Servier Parties' and the Company's products), are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Servier's and the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that may affect future results include, among others, delay or fail